Why Diversity in Genomic Research Matters for Precision Medicine
Genomic diversity is essential for accurate, equitable precision medicine. Expanding representation in research improves risk prediction, variant interpretation, and ensures better outcomes for all populations.
Multi-Omics Medicine: The Next Evolution of Precision Healthcare
Multi-omics medicine integrates genomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive view of disease biology. By analyzing multiple molecular layers together, it enables earlier detection, more accurate diagnosis, and more personalized treatment strategies in precision healthcare.
How Biomarker-Guided Medicine Is Changing Everyday Clinical Care
Advances in biomedical research have significantly expanded the role of molecular and physiological indicators in clinical decision-making. Among the most influential of these developments is the increasing use of biomarkers to guide diagnosis, risk assessment, treatment selection, and disease monitoring. Biomarker-guided medicine represents a core component of precision medicine, emphasizing the use of measurable biological signals to inform individualized clinical care.
The Rise of Precision Oncology: How Genomics Is Transforming Cancer Care
Cancer has long been recognized as a biologically heterogeneous disease, yet historically it has often been treated using relatively uniform therapeutic approaches.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
FOLLOW US
LEARN ABOUT THE
ABOPM
CUSTOMER CARE
LEGAL
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.